Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

Multiple studies show that women who take Depo-Provera have much higher risk of developing meningiomas ...

I’d rather be at home doing it for myself.” Boynton used the self-injectable version of Depo-Provera for nearly 2 years and ...

Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain ...

A woman from Fife lost part of her eyesight after developing benign tumours in her brain, which she believes are linked to a ...

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a quarter of reproductive health experts prescribe ...

Allen Namagembe is a clinical epidemiologist, a biostatistician, and a global expert on self-injection. She is the Uganda Deputy Project Director and M&E Lead on the Uganda Self-Injection Scale-Up ...

Reversible contraceptives like birth control pills, patches, IUDs and implants do not cause permanent infertility for most ...

NEW YORK (Reuters Health) - A study shows that women who use the injectable contraceptive DMPA (depot medroxyprogesterone acetate) are apt to experience a significant increase in body weight and fat.

Guests and partners in the launch of private sector Depo Medroxy Progesterone Subcutaneous( DMPA- SC) contraceptive which is self-injected. [ Jenipher Wachie, Standard] Pharmacies will now serve as ...